Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$695M |
| 2 |
RTX Corp
RTX
|
+$549M |
| 3 |
Elevance Health
ELV
|
+$458M |
| 4 |
TransUnion
TRU
|
+$364M |
| 5 |
AbbVie
ABBV
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$1.08B |
| 2 |
HES
Hess
HES
|
+$574M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$502M |
| 4 |
Microsoft
MSFT
|
+$405M |
| 5 |
Danaher
DHR
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.44% |
| 2 | Financials | 18.84% |
| 3 | Healthcare | 13.07% |
| 4 | Industrials | 12.94% |
| 5 | Communication Services | 7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Procept Biorobotics
PRCT
$1.15B
| $24M | 0.01% |
571,583
-106,444
| -16% | -$3.62M |
|
|
HRT
552
DELISTED
HireRight Holdings Corporation
HRT
| $23.7M | 0.01% |
1,761,444
-368,950
| -17% | -$4.17M |
|
|
NVMI
553
Nova
NVMI
$12.1B
| $23.6M | 0.01% |
172,134
-104,344
| -38% | -$12.1M |
|
554
Baidu
BIDU
$37.1B
| $23.3M | 0.01% |
195,687
+4,214
| +2% | +$487K |
|
|
SASR
555
DELISTED
Sandy Spring Bancorp Inc
SASR
| $23.3M | 0.01% |
854,774
+4,855
| +0.6% | +$110K |
|
556
Neurocrine Biosciences
NBIX
$16.2B
| $23.2M | 0.01% |
175,777
-133
| -0.1% | -$15.3K |
|
557
Funko
FNKO
$295M
| $22.7M | 0.01% |
2,938,799
-8,549
| -0.3% | -$61.8K |
|
558
Watts Water Technologies
WTS
$12.6B
| $22.1M | 0.01% |
106,184
-2,059
| -2% | -$389K |
|
|
AVDX
559
DELISTED
AvidXchange
AVDX
| $22.1M | 0.01% |
1,783,275
+352,540
| +25% | +$3.52M |
|
560
ATS Corp
ATS
$1.99B
| $22M | 0.01% |
509,845
+3,022
| +0.6% | +$117K |
|
561
Dollar Tree
DLTR
$24.9B
| $21.9M | 0.01% |
154,480
-1,358
| -0.9% | -$161K |
|
562
Cactus
WHD
$5.5B
| $21.8M | 0.01% |
480,696
-263,676
| -35% | -$12M |
|
563
Alnylam Pharmaceuticals
ALNY
$28.9B
| $21.5M | 0.01% |
112,240
-575,988
| -84% | -$98.1M |
|
564
Monro
MNRO
$388M
| $21.4M | 0.01% |
730,809
+3,156
| +0.4% | +$88.8K |
|
565
Immunocore
IMCR
$1.75B
| $21.4M | 0.01% |
312,608
+261
| +0.1% | +$13.6K |
|
|
NARI
566
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $21.1M | 0.01% |
324,407
-94,884
| -23% | -$5.71M |
|
567
Fortune Brands Innovations
FBIN
$6.01B
| $21M | 0.01% |
275,306
-1,210,299
| -81% | -$79.7M |
|
568
Texas Roadhouse
TXRH
$13.7B
| $20.8M | 0.01% |
170,303
-10,892
| -6% | -$1.16M |
|
569
Tenaris
TS
$27B
| $20.7M | 0.01% |
595,971
+11,709
| +2% | +$393K |
|
570
FirstService
FSV
$6.27B
| $20.6M | 0.01% |
127,067
-898
| -0.7% | -$136K |
|
571
Collegium Pharmaceutical
COLL
$944M
| $20.5M | 0.01% |
665,118
+599
| +0.1% | +$15K |
|
572
Cheniere Energy
LNG
$54.9B
| $20M | 0.01% |
117,264
+547
| +0.5% | +$94K |
|
573
Emerson Electric
EMR
$87.5B
| $20M | 0.01% |
+205,526
| New | +$18.8M |
|
574
SAP
SAP
$230B
| $20M | 0.01% |
129,374
+6,372
| +5% | +$922K |
|
575
Moog Inc Class A
MOG.A
$13B
| $19.7M | 0.01% |
+136,327
| New | +$17.6M |
|
Similar funds
Massachusetts Financial Services's Q4 2023 Portfolio in Review
As of Q4 2023, Massachusetts Financial Services held 885 positions worth $310B, up 8.4% from $286B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Massachusetts Financial Services's Q4 2023 filing shows 49 new, 322 increased, 455 reduced and 51 closed positions. Its largest new stake was Elevance Health: 990,628 shares worth $467M. The largest sale was Thermo Fisher Scientific, an estimated $1.08B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Massachusetts Financial Services's largest Q4 2023 buy was Elevance Health: 990,628 shares worth $467M.
- Massachusetts Financial Services added most to Chevron in Q4 2023, an estimated $695M increase.
- Massachusetts Financial Services's biggest Q4 2023 reduction was Thermo Fisher Scientific, cutting an estimated $1.08B.
- Massachusetts Financial Services fully exited Caterpillar in Q4 2023, selling an estimated $146M.
- Massachusetts Financial Services's ten largest holdings make up 19% of its $310B portfolio in Q4 2023.
- Massachusetts Financial Services opened 49 new positions and closed 51 in Q4 2023.
- Massachusetts Financial Services's portfolio value rose 8.4% quarter-over-quarter to $310B.
Based on Massachusetts Financial Services's 13F filing for Q4 2023, filed 8 Feb 2024.